ArticleProtein science : a publication of the Protein Society2025
AutoRevDock: An open-source toolkit for scalable reverse docking.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AutoRevDock: An open-source toolkit for scalable reverse docking.Protein science : a publication of the Protein Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Reverse docking is a pivotal computational strategy for drug repurposing and polypharmacology studies, yet existing tools often suffer from limitations in throughput, accuracy, and reliance on centralized servers. To overcome these challenges, we present AutoRevDock, an open-source Python toolkit designed to streamline and enhance the reverse docking workflow. Key features include: (1) support for two established docking engines (AutoDock Vina and idock) with a hybrid scoring scheme (Vina_SFCT, combining the Vina score with a scoring function correction term (SFCT)); (2) pre-processed target libraries covering the human proteome and DrugBank pharmacologically active targets; (3) support for custom target libraries and fully automated local execution. Benchmark evaluations demonstrate that idock operates over 40 times faster than AutoDock Vina. For multiple-target drugs, Vina_SFCT outperforms the default scoring function in identifying biologically relevant targets. Furthermore, incorporating protein family information leads to increased hit rates, suggesting enhanced predictive power for real-world applications. By combining robust methodology with user-centric design, AutoRevDock offers a scalable solution for high-throughput target fishing in drug discovery. The toolkit is freely available at https://github.com/AI4Bio-GuoLAB/AutoRevDock.git.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.